STOCK TITAN

Vivid Seats Inc. (SEAT) Financials

SEAT
FY2025 annual
Revenue $450.5M -30.5% YoY
Net Income $806.1M +5903.2% YoY
Free Cash Flow -$93.8M -288.7% YoY
Operating Cash Flow -$91.6M -269.9% YoY
Market Cap $36.1M as of Oct 10, 2026
Price / Sales 0.1x on $403.8M revenue, trailing 12 months to June 30, 2026
Price / Earnings 0.0x on $806.1M net income, FY2025
Price / Book n/m negative shareholder equity, so no book multiple, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SEAT SEC filings page.

Vivid Seats Inc. (SEAT) reported $450.5M in revenue for fiscal year 2025, down 30.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SEAT FY2025

Vivid Seats’ reported 2025 profit was not matched by operating cash, while revenue fell and the balance sheet weakened.

FY2025 net income of $806.1M contrasted with operating cash flow of -$91.6M, so the headline earnings figure did not translate into cash from operations. Revenue fell from $647.9M in FY2024 to $450.5M in FY2025, making the earnings surge especially disconnected from current sales activity.

Total assets fell from $1.6B to $636.9M, indicating a major balance-sheet contraction. Equity moved from positive to negative, while a 0.6x current ratio leaves current liabilities above current assets; reported liquidity equaled 13.5 months of annual operating outflow.

FY2023 and FY2024 both produced positive free cash flow, but FY2025 reversed to a $93.8M shortfall even as capital expenditures were only $2.2M. That reversal points to an operating cash-conversion problem rather than a capital-spending surge.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 19 / 100
Financial Health Score 19/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Vivid Seats Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
0

Not available for Vivid Seats Inc., and counted as zero in the overall score.

Growth
7

Vivid Seats Inc.'s revenue declined 30.5% year-over-year, from $647.9M to $450.5M. This contraction results in a growth score of 7/100.

Leverage
82
Liquidity
6

Vivid Seats Inc.'s current ratio of 0.59 is below the typical benchmark, resulting in a score of 6/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
19

Vivid Seats Inc.'s operations used $91.6M of cash, and capex of $2.2M added to the outflow, for a free cash flow shortfall of $93.8M. This results in a cash flow score of 19/100.

Returns
0

Not available for Vivid Seats Inc., and counted as zero in the overall score.

Piotroski F-Score Partial
3/7

Vivid Seats Inc. passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality No Cash Backing

For every $1 of reported earnings, Vivid Seats Inc. used $0.11 of operating cash (-$91.6M OCF vs $806.1M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$103.9M
YoY-9.2%
QoQ+6.6%
5Y CAGR-2.1%

Vivid Seats Inc. generated $103.9M in revenue in Q2 2026. This represents a decrease of 9.2% from the same quarter a year earlier. Against the prior quarter it is up 6.6%.

EBITDA

Not reported for Q2 2026.

Net Income

Not reported for Q2 2026.

EPS (Diluted)

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow
-$799K
YoY+97.2%
QoQ-101.7%

Vivid Seats Inc. recorded an outflow of $799K in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents an increase of 97.2% from the same quarter a year earlier. Against the prior quarter it is down 101.7%.

Cash & Debt
$136.7M
YoY-10.7%
QoQ-4.8%
5Y CAGR-21.6%

Vivid Seats Inc. held $136.7M in cash against $15.3M in long-term debt as of Q2 2026, with $378.6M of liabilities due within a year.

Shares Outstanding
11M
QoQ+2.3%

Vivid Seats Inc. had 11M shares outstanding in Q2 2026. Against the prior quarter it is up 2.3%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

None of these metrics is reported for Q2 2026.

Capital Allocation

Share Buybacks
$0
YoY-100.0%

Vivid Seats Inc. repurchased no shares in Q2 2026. This represents a decrease of 100.0% from the same quarter a year earlier.

Capital Expenditures
$0
YoY-100.0%
QoQ-100.0%

Vivid Seats Inc. reported no capital expenditure in Q2 2026. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.

R&D Spending

Not reported for Q2 2026.

SEAT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SEAT quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$103.9M-9.2%$97.5M-27.1%$97.5M-41.0%$104.8M-31.3%$114.5M-32.7%$133.7M-16.4%$165.2M-1.2%$152.7M-1.1%
Net IncomeN/A-$14.6M-38.6%$1.2B+12369.2%-$30.2M-384.5%-$335.4M-76653.1%-$10.6M-182.0%-$9.6M-148.5%$10.6M+59.2%
EPS (Diluted)N/A-$1.35-43.6%N/AN/AN/A-$0.94N/AN/A
Diluted Shares (Avg)N/A11M+3.4%N/AN/AN/A10MN/AN/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, EPS (Basic).

SEAT Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SEAT quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$688.8M-40.1%$691.7M-56.9%$636.9M-61.1%$1.1B-31.3%$1.1B-30.5%$1.6B+1.0%$1.6B+5.5%$1.6B+16.3%
Current Assets$248.7M-6.1%$243.3M-23.9%$178.5M-48.3%$233.9M-28.2%$264.9M-28.6%$319.8M+7.7%$345.2M+40.3%$325.9M-19.6%
Cash & Equivalents$136.7M-10.7%$143.6M-28.0%$102.7M-57.8%$145.1M-28.3%$153.0M-34.7%$199.5M+29.5%$243.5M+94.0%$202.3M-24.7%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$26.9M-17.5%$28.9M+4.4%$18.2M-7.3%$23.6M+5.9%$32.6M+7.8%$27.7M-6.3%$19.6M-6.7%$22.3M+3.3%
Accounts Receivable$59.1M-4.6%$49.3M-28.7%$43.5M-27.8%$51.2M$62.0M$69.2M$60.3M-12.0%N/A
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$283.5M-56.4%$283.7M-70.0%$283.9M-69.9%$648.6M-31.5%$649.4M-31.0%$945.3M+0.1%$943.1M-0.4%$946.9M+24.6%
Total Liabilities$793.9M-1.1%$787.1M-21.2%$722.0M-47.5%$771.6M-39.8%$803.1M-46.4%$999.2M-31.1%$1.4B-4.9%$1.3B-14.9%
Current Liabilities$378.6M+3.1%$371.1M-10.9%$303.3M-28.8%$348.2M-15.6%$367.1M-21.8%$416.3M-20.7%$425.8M-12.7%$412.7M-9.1%
Non-Current Liabilities$415.3M-4.8%$416.0M-28.6%$418.7M-55.9%$423.4M-27.8%$436.0M-26.2%$582.9M+24.6%$949.2M+99.6%$586.4M+42.8%
Long-Term Debt$15.3M-13.7%$15.9M-12.9%$16.5M-12.2%$17.1M+8.1%$17.7M+9.7%$18.2M+16.4%$18.7M+15.5%$15.8M-0.8%
Total Equity-$105.1M-148.3%-$95.4M-125.1%-$85.1M-132.6%$272.2M-17.4%$217.3M+39.5%$380.7M+172.8%$261.1M+148.6%$329.4M+373.9%
Retained Earnings-$1.4B-29.1%-$1.4B-46.8%-$1.4B-46.2%-$1.1B-16.7%-$1.1B-15.1%-$936.1M-0.3%-$930.2M+1.0%-$929.3M+3.7%

SEAT Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SEAT quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow-$799K+97.2%$46.0M+281.9%-$38.2M-179.9%$512K+102.7%-$28.6M-107.3%-$25.3M-164.6%$47.8M+45.1%-$19.2M-160.6%
Depreciation & Amortization$12.3M-0.2%$12.3M+5.9%$11.7M-7.0%$13.7M+28.6%$12.3M+17.5%$11.6M+10.9%$12.6M+46.8%$10.7M+223.2%
Stock-Based CompensationN/A$4.4M-58.9%N/AN/AN/A$10.8M+26.7%N/AN/A
Capital Expenditures$0-100.0%$23K-98.7%$111K-96.8%$10K-97.4%$207K-27.6%$1.8M+1895.7%$3.5M+3045.5%$389K+117.3%
Free Cash Flow-$799K+97.2%$46.0M+269.5%-$38.3M-186.4%$502K+102.6%-$28.8M-104.6%-$27.1M-169.4%$44.3M+35.0%-$19.6M-162.2%
Investing Cash Flow-$3.8M+6.6%-$3.1M+59.0%-$3.9M+56.1%-$4.6M+36.9%-$4.1M+22.2%-$7.6M-43.2%-$8.9M+94.2%-$7.3M+88.9%
Financing Cash Flow-$1.8M+86.8%-$1.8M+84.3%$96K+105.3%-$4.0M+41.2%-$13.9M-114.0%-$11.6M-150.8%-$1.8M+89.2%-$6.8M-63.0%
Share Buybacks$0-100.0%$0-100.0%$3K-81.3%$2.4M-17.0%$9.9M-41.8%$6.0M+93.0%-$16K-99.9%$2.9M

Not reported in any period shown, so not listed: Dividends Paid.

SEAT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SEAT quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Net MarginN/A-15.0%-7.1pp1212.8%-28.8%-35.8pp-293.0%-7.9%-15.9pp-5.8%-17.7pp7.0%+2.6pp
Return on EquityN/AN/AN/A-11.1%-14.3pp-154.3%-154.1pp-2.8%-12.0pp-3.7%-22.6pp3.2%
Return on AssetsN/A-2.1%-1.5pp185.6%+186.2pp-2.7%-3.4pp-29.2%-29.1pp-0.7%-1.5pp-0.6%-1.9pp0.7%+0.2pp
Current Ratio0.66-0.1x0.66-0.1x0.59-0.2x0.67-0.1x0.72-0.1x0.77+0.2x0.81+0.3x0.79-0.1x
Debt-to-EquityN/AN/AN/A0.060.0x0.080.0x0.05-0.1x0.07-0.1x0.05
Asset Turnover0.15+0.1x0.14+0.1x0.15+0.1x0.090.0x0.100.0x0.080.0x0.100.0x0.090.0x
FCF Margin-0.8%+24.4pp47.1%+67.4pp-39.3%-66.1pp0.5%+13.3pp-25.2%-16.9pp-20.3%-44.7pp26.8%+7.2pp-12.8%-33.3pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.

Note: Shareholder equity is negative (-$85.1M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.59), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Vivid Seats Inc. SEAT FY2025 $450.5M $806.1M N/A $36.1M 19/100
TrueCar, Inc. TRUE FY2024 $175.6M -$31.0M -17.7% $225.9M 64/100
Strive, Inc. ASST FY2024 $3.6M -$21.6M N/A $2.8B 38/100
DouYu International Holdings Limited DOYU FY2025 $546.1M -$4.2M -0.8% $119.8M 35/100
The Arena Group Holdings, Inc. AREN FY2025 $134.8M $124.9M 92.6% $53.3M 44/100

Frequently Asked Questions

What is Vivid Seats Inc.'s annual revenue?

Vivid Seats Inc. (SEAT) reported $450.5M in total revenue for fiscal year 2025. This represents a -30.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Vivid Seats Inc.'s revenue growing?

Vivid Seats Inc. (SEAT) revenue declined by 30.5% year-over-year, from $647.9M to $450.5M in fiscal year 2025.

Is Vivid Seats Inc. profitable?

Yes, Vivid Seats Inc. (SEAT) reported a net income of $806.1M in fiscal year 2025.

As of fiscal year 2025, Vivid Seats Inc. (SEAT) had $102.7M in cash and equivalents against $16.5M in long-term debt.

Vivid Seats Inc. (SEAT) recorded an outflow of $93.8M in free cash flow during fiscal year 2025. This represents a -288.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Vivid Seats Inc. (SEAT) recorded an outflow of $91.6M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Vivid Seats Inc. (SEAT) had $636.9M in total assets as of fiscal year 2025, including both current and long-term assets.

Vivid Seats Inc. (SEAT) invested $2.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Vivid Seats Inc. (SEAT) spent $18.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Vivid Seats Inc. (SEAT) had 11M shares outstanding as of fiscal year 2025.

Vivid Seats Inc. (SEAT) had a current ratio of 0.59 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Vivid Seats Inc. (SEAT) had a return on assets of 126.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Vivid Seats Inc. (SEAT) trades at 0.0x earnings, its market capitalization divided by net income of $806.1M net income, FY2025. The market capitalization is $36.1M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Vivid Seats Inc. (SEAT) trades at 0.1x sales, its market capitalization divided by revenue of $403.8M revenue, trailing 12 months to June 30, 2026. The market capitalization is $36.1M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, Vivid Seats Inc. (SEAT) held $102.7M in cash, cash equivalents and investments, and reported an operating cash outflow of $91.6M over that year. Dividing the one by the other, the reported balance equals about 13 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Vivid Seats Inc. (SEAT) has negative shareholder equity of -$85.1M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Vivid Seats Inc. (SEAT) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

For every $1 of reported earnings, Vivid Seats Inc. (SEAT) used $0.11 of operating cash (-$91.6M OCF vs $806.1M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Vivid Seats Inc. (SEAT) scores 19 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top